We are excited to announce the addition of two new members to the Vernal team! Scott Vanson, Ph.D. and JJ Bivona, Ph.D. are bringing their mRNA and DNA experience to Vernal to help accelerate our growth.

Vernal Biosciences, a Colchester-based mRNA and lipid nanoparticle process (LNP) development and manufacturing organization, has been awarded a $99,475 grant from the Vermont Training Program (VTP).

We recently completed a biodistribution study of lipid nanoparticles containing mRNA encoding luciferase in mice. Luciferase will light up it's substrate, luciferin, where ever luciferase is expressed from the mRNA.

Vernal Biosciences, Inc., a manufacturer of high purity mRNA for research and clinical use, today announced the closing of a seed round of financing.